Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiviral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002312
What this trial is testing

The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take Zidovudine

Who this might be right for
HIV Infections
Pharmacia and Upjohn
Testing effectiveness (Phase 2)Study completedNCT04743011
What this trial is testing

Enriched Heparin Anti COVID-19 Trial

Who this might be right for
Covid19
UPECLIN HC FM Botucatu Unesp 27
Not applicableStudy completedNCT00002187
What this trial is testing

ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Ionis Pharmaceuticals, Inc.
Post-approval studies (Phase 4)Study completedNCT01195181
What this trial is testing

Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

Who this might be right for
Hepatitis C VirusChronic Liver DiseaseViral Hepatitis+2 more
Azienda Ospedaliera di Padova 506
Post-approval studies (Phase 4)UnknownNCT04069858
What this trial is testing

Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Korea University 40
Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246
Large-scale testing (Phase 3)Study completedNCT02265913
What this trial is testing

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

Who this might be right for
Herpes Labialis
Padagis LLC 4,076
Large-scale testing (Phase 3)Study completedNCT00002220
What this trial is testing

Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 120
Early research (Phase 1)Study completedNCT00000753
What this trial is testing

A Phase I Concentration-Targeted Multidose Study of Atevirdine Mesylate ( U-87201E ), AZT, and ddI or ddC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00002326
What this trial is testing

The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients

Who this might be right for
HIV Infections
Gilead Sciences 20
Testing effectiveness (Phase 2)Study completedNCT00071760
What this trial is testing

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 59
Post-approval studies (Phase 4)Study completedNCT01045278
What this trial is testing

Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy

Who this might be right for
Hepatitis C
Region Skane 277
Testing effectiveness (Phase 2)Study completedNCT01140997
What this trial is testing

Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Xiamen Amoytop Biotech Co., Ltd. 211
Not applicableStudy completedNCT05294159
What this trial is testing

Implementing Long-Acting Novel Antiretrovirals

Who this might be right for
Human Immunodeficiency Viruses
Queen Mary University of London 114
Testing effectiveness (Phase 2)Study completedNCT00274404
What this trial is testing

Controlled Trial of Valacyclovir in Infectious Mononucleosis

Who this might be right for
Infectious Mononucleosis
University of Minnesota 20
Testing effectiveness (Phase 2)Study completedNCT00460382
What this trial is testing

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 103
Not applicableStudy completedNCT04038320
What this trial is testing

Simplified Antiviral Treatment Strategy for Hepatitis C in Ukraine

Who this might be right for
Hepatitis C Virus
Right to Care 868
Not applicableStudy completedNCT01342003
What this trial is testing

HCV Genotype 1a Shows a Better Virological Response to Antiviral Therapy Than HCV Genotype 1b

Who this might be right for
Chronic Hepatitis C
Azienda Ospedaliera San Camillo Forlanini 388
Testing effectiveness (Phase 2)Study completedNCT01037166
What this trial is testing

Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine Therapy

Who this might be right for
Chronic Hepatitis B
Bristol-Myers Squibb 84
Testing effectiveness (Phase 2)Study completedNCT02818582
What this trial is testing

GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen

Who this might be right for
Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 38
Next Page